Pine Valley Investments Ltd Liability Co

Position in NVS — Novartis AG

CIK 1975417 MARLTON, NJ

Position in NVS

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$1,545,729

+$39,156 QoQ

Shares Held

9,863

0.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#496

of 1,603 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Pine Valley Investments Ltd Liability Co holds $80,398,401 across 12 Drug Manufacturers - General names. NVS ranks #9 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	116,193	$29,509,536
2	ABBV	AbbVie Inc.	72,077	$18,137,456
3	LLY	ELI LILLY & Co	10,622	$12,740,346
4	MRK	Merck & Co., Inc.	54,242	$6,970,097
5	PFE	Pfizer Inc	150,761	$3,630,324
6	BMY	Bristol Myers Squibb Co	43,011	$2,478,293
7	NVO	Novo Nordisk A S	48,469	$2,323,603
8	AMGN	Amgen Inc	4,490	$1,625,918

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,545,729	9,863	0.0%	Shares	Sole	2026-07-24
2026-03-31	$1,506,573	9,863	0.0%	Shares	Sole	2026-06-08
2025-12-31	$1,359,811	9,863	-2.5%	Shares	Sole	2026-02-13
2025-09-30	$1,296,891	10,113	0.0%	Shares	Sole	2026-02-17
2025-06-30	$1,223,774	10,113	-30.0%	Shares	Sole	2026-02-17
2025-03-31	$1,609,436	14,437	-4.0%	Shares	Sole	2026-02-17
2024-12-31	$1,463,250	15,037	0.0%	Shares	Sole	2025-02-04
2024-09-30	$1,729,555	15,037	-0.4%	Shares	Sole	2024-11-25
2024-06-30	$1,606,694	15,092	+20.2%	Shares	Sole	2024-07-30
2024-03-31	$1,214,445	12,555	-0.8%	Shares	Sole	2024-05-08
2023-12-31	$1,278,179	12,659	+11.5%	Shares	Sole	2024-02-14
2023-09-30	$1,156,722	11,356	+6.0%	Shares	Sole	2023-11-08
2023-06-30	$1,081,048	10,713	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.